#USA #Portland, Oregon #Araceli Biosciences #Christine Tsingos #Bio-Rad Laboratories

Araceli Biosciences Welcomes a New Board Member

Araceli Biosciences, a leader in high-performance biological discovery solutions, has officially appointed Christine A. Tsingos to its Board of Directors. This strategic decision aims to leverage Tsingos' extensive experience in financial oversight, governance, and corporate growth as the company embarks on a critical phase of expansion.

Who is Christine Tsingos?

Christine Tsingos brings more than three decades of experience in executive management and board involvement. Her background encompasses areas crucial to corporate success, including financial strategy, capital planning, investor relations, mergers, acquisitions, and information technology. Tsingos’ prior role as the Executive Vice President and Chief Financial Officer at Bio-Rad Laboratories from 2002 to 2019 positioned her at the forefront of the biotechnology sector. She played a pivotal role in guiding the company's sustained growth and strategic expansion.

Bill Cortelyou, Chairman at Araceli Biosciences, expressed confidence in Tsingos' capabilities: "Christine brings a wealth of experience in finance, governance, and strategic leadership at a critical time for the company's growth. Her track record in scaling life sciences companies and driving long-term value creation will strengthen the Board as we support disciplined growth and the next phase of the company's expansion."

Significance of the Appointment

The timing of Tsingos' appointment is particularly significant as Araceli positions itself in the forefront of the AI-driven drug discovery landscape, integrated laboratory systems. CEO Matt Beaudet emphasized the importance of Tsingos’ past experience in transitioning companies from standalone tools to embedded systems within modern laboratory infrastructures. “This experience is crucial for our growth,” Beaudet stated.

Tsingos currently also serves on the boards of Envista Holdings and Varex Imaging Corporation, and has previously been part of the boards of Onto Innovation and Telesis Bio. Her diverse roles reinforce her extensive understanding of the business dynamics essential for Araceli Biosciences' trajectory.

Academic and Professional Credentials

In addition to her practical experience, Tsingos boasts an academic background that includes a Bachelor’s degree in International Studies from American University and an MBA in International Business from George Washington University. Her achievements have not gone unnoticed; she was recognized as the Bay Area Financial Executive of the Year by the San Francisco Business Times in 2010, a testament to her influence and standing in the industry.

A Vision for Growth

Expressing her enthusiasm for her new role, Tsingos stated, "Araceli has gained significant momentum in a short span, reflecting both the robustness of its technology and a clear market need. We are now focusing on laying the groundwork for supporting that growth on a large scale, and I am excited to be part of it."

About Araceli Biosciences

Araceli Biosciences is dedicated to enhancing biological discovery through ultra-high-performance imaging solutions. The company assists researchers in generating comprehensive data to expedite decision-making in drug discovery workflows and life sciences research.

With Christine Tsingos now on board, Araceli Biosciences is well-positioned to navigate the complexities of the evolving biotech landscape as it continues to innovate and expand its offerings.